Home > Insider Trading > Filing (0001181431-15-007242)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885306	Cynosure Inc	CYNO	Electromedical & Electrotherapeutic Apparatus (3845)	043125110

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1345794	J Douglas Delaney	C/O Cynosure, Inc. 5 Carlisle Road Westford MA 01886	Executive Vp, Sales	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2015-05-19	40,000	$22.12	40,000	No	4	M	Direct
Class A Common Stock	Acquisiton	2015-05-19	15,912	$22.65	15,912	No	4	M	Direct
Class A Common Stock	Disposition	2015-05-19	55,912	$38.00	0	No	4	S	Direct
Class A Common Stock	Acquisiton	2015-05-20	14,088	$22.65	14,088	No	4	M	Direct
Class A Common Stock	Acquisiton	2015-05-20	19,000	$23.97	19,000	No	4	M	Direct
Class A Common Stock	Disposition	2015-05-20	33,088	$38.03	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2015-05-19	40,000	$0.00	40,000	$22.12
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2015-05-19	15,912	$0.00	15,912	$22.65
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2015-05-20	14,088	$0.00	14,088	$22.65
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2015-05-20	19,000	$0.00	19,000	$23.97

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2023-10-30	No	4	M	Direct
14,088	2017-02-14	No	4	M	Direct
0	2017-02-14	No	4	M	Direct
0	2018-02-13	No	4	M	Direct

Footnotes

The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $38.00 to $38.08 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option became exercisable as to approximately 25% of the shares on each three-month anniversary of the 10/30/2013 grant date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/14/2007 grant date.
The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $38.00 to $38.34 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/13/2008 grant date.